{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["ILC2", "allergic inflammation", "allergy", "eosinophils", "lipid mediators", "metabolites"]], "OtherAbstract": [], "SpaceFlightMission": [], "InvestigatorList": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "PMID": "39000023", "DateCompleted": {"Year": "2024", "Month": "07", "Day": "13"}, "DateRevised": {"Year": "2024", "Month": "07", "Day": "15"}, "Article": {"Language": ["eng"], "ELocationID": ["6913", "10.3390/ijms25136913"], "ArticleDate": [{"Year": "2024", "Month": "06", "Day": "24"}], "Journal": {"ISSN": "1422-0067", "JournalIssue": {"Volume": "25", "Issue": "13", "PubDate": {"Year": "2024", "Month": "Jun", "Day": "24"}}, "Title": "International journal of molecular sciences", "ISOAbbreviation": "Int J Mol Sci"}, "ArticleTitle": "Deciphering the Interplay between the Epithelial Barrier, Immune Cells, and Metabolic Mediators in Allergic Disease.", "Abstract": {"AbstractText": ["Chronic exposure to harmful pollutants, chemicals, and pathogens from the environment can lead to pathological changes in the epithelial barrier, which increase the risk of developing an allergy. During allergic inflammation, epithelial cells send proinflammatory signals to group 2 innate lymphoid cell (ILC2s) and eosinophils, which require energy and resources to mediate their activation, cytokine/chemokine secretion, and mobilization of other cells. This review aims to provide an overview of the metabolic regulation in allergic asthma, atopic dermatitis (AD), and allergic rhinitis (AR), highlighting its underlying mechanisms and phenotypes, and the potential metabolic regulatory roles of eosinophils and ILC2s. Eosinophils and ILC2s regulate allergic inflammation through lipid mediators, particularly cysteinyl leukotrienes (CysLTs) and prostaglandins (PGs). Arachidonic acid (AA)-derived metabolites and Sphinosine-1-phosphate (S1P) are significant metabolic markers that indicate immune dysfunction and epithelial barrier dysfunction in allergy. Notably, eosinophils are promoters of allergic symptoms and exhibit greater metabolic plasticity compared to ILC2s, directly involved in promoting allergic symptoms. Our findings suggest that metabolomic analysis provides insights into the complex interactions between immune cells, epithelial cells, and environmental factors. Potential therapeutic targets have been highlighted to further understand the metabolic regulation of eosinophils and ILC2s in allergy. Future research in metabolomics can facilitate the development of novel diagnostics and therapeutics for future application."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Chinese Medicine, State Key Laboratory of Research on Bioactivities and Clinical Applications of Medicinal Plants, The Chinese University of Hong Kong, Hong Kong, China."}], "LastName": "Kan", "ForeName": "Lea Ling-Yu", "Initials": "LL"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Chinese Medicine, State Key Laboratory of Research on Bioactivities and Clinical Applications of Medicinal Plants, The Chinese University of Hong Kong, Hong Kong, China."}], "LastName": "Li", "ForeName": "Peiting", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemical Pathology, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong, China."}], "LastName": "Hon", "ForeName": "Sharon Sze-Man", "Initials": "SS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Chinese Medicine, State Key Laboratory of Research on Bioactivities and Clinical Applications of Medicinal Plants, The Chinese University of Hong Kong, Hong Kong, China."}], "LastName": "Lai", "ForeName": "Andrea Yin-Tung", "Initials": "AY"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Biomedical Sciences, The Chinese University of Hong Kong, Hong Kong, China."}], "LastName": "Li", "ForeName": "Aixuan", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemical Pathology, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong, China."}], "LastName": "Wong", "ForeName": "Katie Ching-Yau", "Initials": "KC"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemical Pathology, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong, China."}], "LastName": "Huang", "ForeName": "Danqi", "Initials": "D"}, {"Identifier": ["0000-0002-5637-8331"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Chinese Medicine, State Key Laboratory of Research on Bioactivities and Clinical Applications of Medicinal Plants, The Chinese University of Hong Kong, Hong Kong, China."}, {"Identifier": [], "Affiliation": "Department of Chemical Pathology, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong, China."}, {"Identifier": [], "Affiliation": "Li Dak Sum Yip Yio Chin R & D Centre for Chinese Medicine, The Chinese University of Hong Kong, Hong Kong, China."}], "LastName": "Wong", "ForeName": "Chun-Kwok", "Initials": "CK"}], "GrantList": [{"GrantID": "00000", "Agency": "Innovation and Technology Commission", "Country": ""}, {"GrantID": "00000", "Agency": "Li Dak Sum Yip Yio Chin R & D Centre for Chinese Medicine", "Country": ""}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Int J Mol Sci", "NlmUniqueID": "101092791", "ISSNLinking": "1422-0067"}, "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["metabolism", "immunology"], "DescriptorName": "Hypersensitivity"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["metabolism", "immunology"], "DescriptorName": "Eosinophils"}, {"QualifierName": ["metabolism", "immunology"], "DescriptorName": "Epithelial Cells"}, {"QualifierName": [], "DescriptorName": "Immunity, Innate"}, {"QualifierName": ["immunology", "metabolism", "pathology"], "DescriptorName": "Dermatitis, Atopic"}, {"QualifierName": ["metabolism", "immunology"], "DescriptorName": "Lymphocytes"}, {"QualifierName": ["metabolism", "immunology"], "DescriptorName": "Rhinitis, Allergic"}], "CoiStatement": "The authors declare no conflicts of interest."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Qiu S., Cai Y., Yao H., Lin C., Xie Y., Tang S., Zhang A. Small molecule metabolites: Discovery of biomarkers and therapeutic targets. Signal Transduct. Target. Ther. 2023;8:132.", "ArticleIdList": ["PMC10026263", "36941259"]}, {"Citation": "Baker S.A., Rutter J. Metabolites as signalling molecules. Nat. Rev. Mol. Cell Biol. 2023;24:355\u2013374. doi: 10.1038/s41580-022-00572-w.", "ArticleIdList": ["10.1038/s41580-022-00572-w", "36635456"]}, {"Citation": "Li F., Xu W., Zhao S. Regulatory roles of metabolites in cell signaling networks. J. Genet. Genom. 2013;40:367\u2013374. doi: 10.1016/j.jgg.2013.05.002.", "ArticleIdList": ["10.1016/j.jgg.2013.05.002", "23876777"]}, {"Citation": "Samitas K., Carter A., Kariyawasam H.H., Xanthou G. Upper and lower airway remodelling mechanisms in asthma, allergic rhinitis and chronic rhinosinusitis: The one airway concept revisited. Allergy. 2018;73:993\u20131002. doi: 10.1111/all.13373.", "ArticleIdList": ["10.1111/all.13373", "29197105"]}, {"Citation": "Qin Z., Chen Y., Wang Y., Xu Y., Liu T., Mu Q., Huang C. Immunometabolism in the pathogenesis of asthma. Immunology. 2024;171:1\u201317. doi: 10.1111/imm.13688.", "ArticleIdList": ["10.1111/imm.13688", "37652466"]}, {"Citation": "Hotamisligil G.S. Foundations of Immunometabolism and Implications for Metabolic Health and Disease. Immunity. 2017;47:406\u2013420. doi: 10.1016/j.immuni.2017.08.009.", "ArticleIdList": ["10.1016/j.immuni.2017.08.009", "PMC5627521", "28930657"]}, {"Citation": "Vitte J., Vibhushan S., Bratti M., Montero-Hernandez J.E., Blank U. Allergy, Anaphylaxis, and Nonallergic Hypersensitivity: IgE, Mast Cells, and Beyond. Med. Princ. Pract. 2022;31:501\u2013515. doi: 10.1159/000527481.", "ArticleIdList": ["10.1159/000527481", "PMC9841766", "36219943"]}, {"Citation": "Wang J., Zhou Y., Zhang H., Hu L., Liu J., Wang L., Wang T., Zhang H., Cong L., Wang Q. Pathogenesis of allergic diseases and implications for therapeutic interventions. Signal Transduct. Target. Ther. 2023;8:138. doi: 10.1038/s41392-023-01344-4.", "ArticleIdList": ["10.1038/s41392-023-01344-4", "PMC10039055", "36964157"]}, {"Citation": "Falcon R.M.G., Caoili S.E.C. Immunologic, genetic, and ecological interplay of factors involved in allergic diseases. Front. Allergy. 2023;4:1215616. doi: 10.3389/falgy.2023.1215616.", "ArticleIdList": ["10.3389/falgy.2023.1215616", "PMC10435091", "37601647"]}, {"Citation": "Leon B. Understanding the development of Th2 cell-driven allergic airway disease in early life. Front. Allergy. 2023;3:1080153. doi: 10.3389/falgy.2022.1080153.", "ArticleIdList": ["10.3389/falgy.2022.1080153", "PMC9872036", "36704753"]}, {"Citation": "Goretzki A., Lin Y.J., Sch\u00fclke S. Immune metabolism in allergies, does it matter?\u2014A review of immune metabolic basics and adaptations associated with the activation of innate immune cells in allergy. Allergy. 2021;76:3314\u20133331. doi: 10.1111/all.14843.", "ArticleIdList": ["10.1111/all.14843", "33811351"]}, {"Citation": "Michaeloudes C., Bhavsar P.K., Mumby S., Xu B., Hui C.K.M., Chung K.F., Adcock I.M. Role of Metabolic Reprogramming in Pulmonary Innate Immunity and Its Impact on Lung Diseases. J. Innate Immun. 2020;12:31\u201346. doi: 10.1159/000504344.", "ArticleIdList": ["10.1159/000504344", "PMC6959099", "31786568"]}, {"Citation": "Purohit V., Wagner A., Yosef N., Kuchroo V.K. Systems-based approaches to study immunometabolism. Cell. Mol. Immunol. 2022;19:409\u2013420. doi: 10.1038/s41423-021-00783-9.", "ArticleIdList": ["10.1038/s41423-021-00783-9", "PMC8891302", "35121805"]}, {"Citation": "Russell C., Rahman A., Mohammed A.R. Application of genomics, proteomics and metabolomics in drug discovery, development and clinic. Ther. Deliv. 2013;4:395\u2013413. doi: 10.4155/tde.13.4.", "ArticleIdList": ["10.4155/tde.13.4", "23442083"]}, {"Citation": "Kucuksezer U.C., Ozdemir C., Yazici D., Pat Y., Mitamura Y., Li M., Sun N., D\u2019Avino P., Bu X., Zhu X., et al. The epithelial barrier theory: Development and exacerbation of allergic and other chronic inflammatory diseases. Asia Pac. Allergy. 2023;13:28\u201339. doi: 10.5415/apallergy.0000000000000005.", "ArticleIdList": ["10.5415/apallergy.0000000000000005", "PMC10166244", "37389096"]}, {"Citation": "Adams K., Weber K.S., Johnson S.M. Exposome and Immunity Training: How Pathogen Exposure Order Influences Innate Immune Cell Lineage Commitment and Function. Int. J. Mol. Sci. 2020;21:8462. doi: 10.3390/ijms21228462.", "ArticleIdList": ["10.3390/ijms21228462", "PMC7697998", "33187101"]}, {"Citation": "Losol P., Sokolowska M., Hwang Y.K., Ogulur I., Mitamura Y., Yazici D., Pat Y., Radzikowska U., Ardicli S., Yoon J.E., et al. Epithelial Barrier Theory: The Role of Exposome, Microbiome, and Barrier Function in Allergic Diseases. Allergy Asthma Immunol. Res. 2023;15:705\u2013724. doi: 10.4168/aair.2023.15.6.705.", "ArticleIdList": ["10.4168/aair.2023.15.6.705", "PMC10643858", "37957791"]}, {"Citation": "Campbell B.E., Lodge C.J., Lowe A.J., Burgess J.A., Matheson M.C., Dharmage S.C. Exposure to \u2018farming\u2019 and objective markers of atopy: A systematic review and meta-analysis. Clin. Exp. Allergy. 2015;45:744\u2013757. doi: 10.1111/cea.12429.", "ArticleIdList": ["10.1111/cea.12429", "25270644"]}, {"Citation": "Illi S., Depner M., Genuneit J., Horak E., Loss G., Strunz-Lehner C., B\u00fcchele G., Boznanski A., Danielewicz H., Cullinan P., et al. Protection from childhood asthma and allergy in Alpine farm environments-the GABRIEL Advanced Studies. J. Allergy Clin. Immunol. 2012;129:1470\u20131477.e6. doi: 10.1016/j.jaci.2012.03.013.", "ArticleIdList": ["10.1016/j.jaci.2012.03.013", "22534534"]}, {"Citation": "K\u00e4\u00e4ri\u00f6 H., Huttunen K., Karvonen A.M., Schaub B., von Mutius E., Pekkanen J., Hirvonen M.R., Roponen M. Exposure to a farm environment is associated with T helper 1 and regulatory cytokines at age 4.5 years. Clin. Exp. Allergy. 2016;46:71\u201377. doi: 10.1111/cea.12636.", "ArticleIdList": ["10.1111/cea.12636", "26362849"]}, {"Citation": "Deckers J., Marsland B.J., von Mutius E. Protection against allergies: Microbes, immunity, and the farming effect. Eur. J. Immunol. 2021;51:2387\u20132398. doi: 10.1002/eji.202048938.", "ArticleIdList": ["10.1002/eji.202048938", "34415577"]}, {"Citation": "Wegmann M. Trained immunity in allergic asthma. J. Allergy Clin. Immunol. 2023;151:1471\u20131473. doi: 10.1016/j.jaci.2023.02.023.", "ArticleIdList": ["10.1016/j.jaci.2023.02.023", "36868321"]}, {"Citation": "Akdis C.A. Does the epithelial barrier hypothesis explain the increase in allergy, autoimmunity and other chronic conditions? Nat. Rev. Immunol. 2021;21:739\u2013751. doi: 10.1038/s41577-021-00538-7.", "ArticleIdList": ["10.1038/s41577-021-00538-7", "33846604"]}, {"Citation": "Mitamura Y., Ogulur I., Pat Y., Rinaldi A.O., Ardicli O., Cevhertas L., Br\u00fcggen M.C., Traidl-Hoffman C., Akdis M., Akdis C.A. Dysregulation of the epithelial barrier by environmental and other exogenous factors. Contact Dermat. 2021;85:615\u2013626. doi: 10.1111/cod.13959.", "ArticleIdList": ["10.1111/cod.13959", "PMC9293165", "34420214"]}, {"Citation": "Yazici D., Ogulur I., Kucukkase O., Li M., Ronaldi A.O., Pat Y., Wallimann A., Wawrocki S., S\u00f6zener Z.C., Buyuktiryaki B., et al. Epithelial barrier hypothesis and the development of allergic and autoimmune diseases. Allergo J. Int. 2022;31:91\u2013102. doi: 10.1007/s40629-022-00211-y.", "ArticleIdList": ["10.1007/s40629-022-00211-y"]}, {"Citation": "Pat Y., Yazici D., D\u2019Avino P., Li M., Ardicli S., Ardicli O., Mitamura Y., Akdis M., Dhir R., Nadeau K., et al. Recent advances in the epithelial barrier theory. Int. Immunol. 2024;36:211\u2013222. doi: 10.1093/intimm/dxae002.", "ArticleIdList": ["10.1093/intimm/dxae002", "PMC10989673", "38227765"]}, {"Citation": "Mija\u010d S., Bani\u0107 I., Genc A.M., Lipej M., Turkalj M. The Effects of Environmental Exposure on Epigenetic Modifications in Allergic Diseases. Medicina. 2024;60:110. doi: 10.3390/medicina60010110.", "ArticleIdList": ["10.3390/medicina60010110", "PMC10820670", "38256371"]}, {"Citation": "S\u00f6zener Z.C., Cevhertas L., Nadeau K., Akdis M., Akdis C.A. Environmental factors in epithelial barrier dysfunction. J. Allergy Clin. Immunol. 2020;145:1517\u20131528. doi: 10.1016/j.jaci.2020.04.024.", "ArticleIdList": ["10.1016/j.jaci.2020.04.024", "32507229"]}, {"Citation": "Sozener Z.C., Y\u00fccel \u00dc.\u00d6., Altiner S., Ozt\u00fcrk B.O., Cerci P., T\u00fcrk M., Akin B.G., Akdis M., Yilmaz I., Ozdemir C., et al. The External Exposome and Allergies: From the Perspective of the Epithelial Barrier Hypothesis. Front. Allergy. 2022;3:887672.", "ArticleIdList": ["PMC9304993", "35873598"]}, {"Citation": "Zuo L., Kuo W.T., Turner J.R. Tight Junctions as Targets and Effectors of Mucosal Immune Homeostasis. Cell. Mol. Gastroenterol. Hepatol. 2020;10:327\u2013340. doi: 10.1016/j.jcmgh.2020.04.001.", "ArticleIdList": ["10.1016/j.jcmgh.2020.04.001", "PMC7326733", "32304780"]}, {"Citation": "Hellings P.W., Steelant B. Epithelial barriers in allergy and asthma. J. Allergy Clin. Immunol. 2020;145:1499\u20131509. doi: 10.1016/j.jaci.2020.04.010.", "ArticleIdList": ["10.1016/j.jaci.2020.04.010", "PMC7270816", "32507228"]}, {"Citation": "Zhang R., Zhang L., Li P., Pang K., Liu H., Tian L. Epithelial Barrier in the Nasal Mucosa, Related Risk Factors and Diseases. Int. Arch. Allergy Immunol. 2023;184:481\u2013501. doi: 10.1159/000528969.", "ArticleIdList": ["10.1159/000528969", "PMC10137320", "36724763"]}, {"Citation": "Xiao C., Puddicombe S.M., Field S., Haywood J., Broughton-Head V., Puxeddu I., Haitchi H.M., Vernon-Wilson E., Sammut D., Bedke N., et al. Defective epithelial barrier function in asthma. J. Allergy Clin. Immunol. 2011;128:549\u2013556. doi: 10.1016/j.jaci.2011.05.038.", "ArticleIdList": ["10.1016/j.jaci.2011.05.038", "21752437"]}, {"Citation": "Yu L.C., Wang J.T., Wei S.C., Ni Y.H. Host-microbial interactions and regulation of intestinal epithelial barrier function: From physiology to pathology. World J. Gastrointest. Pathophysiol. 2012;3:27\u201343. doi: 10.4291/wjgp.v3.i1.27.", "ArticleIdList": ["10.4291/wjgp.v3.i1.27", "PMC3284523", "22368784"]}, {"Citation": "Barbara G., Barbaro M.R., Fuschi D., Palombo M., Falangone F., Cremon C., Marasco G., Stanghellini V. Inflammatory and Microbiota-Related Regulation of the Intestinal Epithelial Barrier. Front. Nutr. 2021;8:718356. doi: 10.3389/fnut.2021.718356.", "ArticleIdList": ["10.3389/fnut.2021.718356", "PMC8475765", "34589512"]}, {"Citation": "Okumura R., Takeda K. Roles of intestinal epithelial cells in the maintenance of gut homeostasis. Exp. Mol. Med. 2017;49:e338. doi: 10.1038/emm.2017.20.", "ArticleIdList": ["10.1038/emm.2017.20", "PMC5454438", "28546564"]}, {"Citation": "Peterson L.W., Artis D. Intestinal epithelial cells: Regulators of barrier function and immune homeostasis. Nat. Rev. Immunol. 2014;14:141\u2013153. doi: 10.1038/nri3608.", "ArticleIdList": ["10.1038/nri3608", "24566914"]}, {"Citation": "Magalhaes J.G., Tattoli I., Girardin S.E. The intestinal epithelial barrier: How to distinguish between the microbial flora and pathogens. Semin. Immunol. 2007;19:106\u2013115. doi: 10.1016/j.smim.2006.12.006.", "ArticleIdList": ["10.1016/j.smim.2006.12.006", "17324587"]}, {"Citation": "Zhang K., Hornef M.W., Dupont A. The intestinal epithelium as guardian of gut barrier integrity. Cell. Microbiol. 2015;17:1561\u20131569. doi: 10.1111/cmi.12501.", "ArticleIdList": ["10.1111/cmi.12501", "26294173"]}, {"Citation": "Edelblum K.L., Turner J.R. Chapter 12\u2014Epithelial cells: Structure, transport, and barrier function. In: Mestecky J., Strober W., Russell M., Kelsall B., Cheroutre H., Lambrecht B., editors. Mucosal Immunology. 4th ed. Volume 1. Academic Press; Cambridge, MA, USA: 2015. pp. 187\u2013210."}, {"Citation": "Lu H.F., Zhou Y.C., Yang L.T., Zhou Q., Wang X.J., Qiu S.Q., Cheng B.H., Zeng X.H. Involvement and repair of epithelial barrier dysfunction in allergic diseases. Front. Immunol. 2024;15:1348272. doi: 10.3389/fimmu.2024.1348272.", "ArticleIdList": ["10.3389/fimmu.2024.1348272", "PMC10867171", "38361946"]}, {"Citation": "Goleva E., Berdyshev E., Leung D.Y. Epithelial barrier repair and prevention of allergy. J. Clin. Investig. 2019;129:1463\u20131474. doi: 10.1172/JCI124608.", "ArticleIdList": ["10.1172/JCI124608", "PMC6436854", "30776025"]}, {"Citation": "van Smeden J., Janssens M., Gooris G.S., Bouwstra J.A. The important role of stratum corneum lipids for the cutaneous barrier function. Biochim. Biophys. Acta. 2014;1841:295\u2013313. doi: 10.1016/j.bbalip.2013.11.006.", "ArticleIdList": ["10.1016/j.bbalip.2013.11.006", "24252189"]}, {"Citation": "Yang G., Seok J.K., Kang H.C., Cho Y.Y., Lee H.S., Lee J.Y. Skin Barrier Abnormalities and Immune Dysfunction in Atopic Dermatitis. Int. J. Mol. Sci. 2020;21:2867. doi: 10.3390/ijms21082867.", "ArticleIdList": ["10.3390/ijms21082867", "PMC7215310", "32326002"]}, {"Citation": "Eming S.A., Wynn T.A., Martin P. Inflammation and metabolism in tissue repair and regeneration. Science. 2017;356:1026\u20131030. doi: 10.1126/science.aam7928.", "ArticleIdList": ["10.1126/science.aam7928", "28596335"]}, {"Citation": "Agrawal R., Woodfolk J.A. Skin barrier defects in atopic dermatitis. Curr. Allergy Asthma Rep. 2014;14:433. doi: 10.1007/s11882-014-0433-9.", "ArticleIdList": ["10.1007/s11882-014-0433-9", "PMC4034059", "24633617"]}, {"Citation": "Rath E., Haller D. Intestinal epithelial cell metabolism at the interface of microbial dysbiosis and tissue injury. Mucosal Immunol. 2022;15:595\u2013604. doi: 10.1038/s41385-022-00514-x.", "ArticleIdList": ["10.1038/s41385-022-00514-x", "PMC9259489", "35534699"]}, {"Citation": "Ganesan S., Comstock A.T., Sajjan U.S. Barrier function of airway tract epithelium. Tissue Barriers. 2013;1:e24997. doi: 10.4161/tisb.24997.", "ArticleIdList": ["10.4161/tisb.24997", "PMC3783221", "24665407"]}, {"Citation": "Izquierdo E., Rodriguez-Coira J., Delgado-Dolset M.I., Gomez-Casado C., Barber D., Escribese M.M. Epithelial Barrier: Protector and Trigger of Allergic Disorders. J. Investig. Allergol. Clin. Immunol. 2022;32:81\u201396. doi: 10.18176/jiaci.0779.", "ArticleIdList": ["10.18176/jiaci.0779", "35029152"]}, {"Citation": "Laidlaw T.M., Mullol J., Woessner K.M., Amin N., Mannent L.P. Chronic Rhinosinusitis with Nasal Polyps and Asthma. J. Allergy Clin. Immunol. Pract. 2021;9:1133\u20131141. doi: 10.1016/j.jaip.2020.09.063.", "ArticleIdList": ["10.1016/j.jaip.2020.09.063", "33065369"]}, {"Citation": "Johnson J.R., Roos A., Berg T., Nord M., Fuxe J. Chronic respiratory aeroallergen exposure in mice induces epithelial-mesenchymal transition in the large airways. PLoS ONE. 2011;6:e16175. doi: 10.1371/journal.pone.0016175.", "ArticleIdList": ["10.1371/journal.pone.0016175", "PMC3024415", "21283768"]}, {"Citation": "Heijink I.H., Postma D.S., Noordhoek J.A., Broekema M., Kapus A. House dust mite-promoted epithelial-to-mesenchymal transition in human bronchial epithelium. Am. J. Respir. Cell. Mol. Biol. 2010;42:69\u201379. doi: 10.1165/rcmb.2008-0449OC.", "ArticleIdList": ["10.1165/rcmb.2008-0449OC", "19372245"]}, {"Citation": "Yizhak K., Benyamini T., Liebermeister W., Ruppin E., Shlomi T. Integrating quantitative proteomics and metabolomics with a genome-scale metabolic network model. Bioinformatics. 2010;26:i255\u2013i260. doi: 10.1093/bioinformatics/btq183.", "ArticleIdList": ["10.1093/bioinformatics/btq183", "PMC2881368", "20529914"]}, {"Citation": "Mogilenko D.A., Sergushichev A., Artyomov M.N. Systems Immunology Approaches to Metabolism. Annu. Rev. Immunol. 2023;41:317\u2013342. doi: 10.1146/annurev-immunol-101220-031513.", "ArticleIdList": ["10.1146/annurev-immunol-101220-031513", "37126419"]}, {"Citation": "Wolowczuk I., Verwaerde C., Viltart O., Delanoye A., Delacre M., Pot B., Grangette C. Feeding our immune system: Impact on metabolism. J. Immunol. Res. 2008;2008:639803. doi: 10.1155/2008/639803.", "ArticleIdList": ["10.1155/2008/639803", "PMC2266987", "18350123"]}, {"Citation": "Sun L., Yang X., Yuan Z., Wang H. Metabolic Reprogramming in Immune Response and Tissue Inflammation. Arterioscler. Thromb. Vasc. Biol. 2020;40:1990\u20132001. doi: 10.1161/ATVBAHA.120.314037.", "ArticleIdList": ["10.1161/ATVBAHA.120.314037", "PMC7484156", "32698683"]}, {"Citation": "O\u2019Neill L.A., Kishton R.J., Rathmell J. A guide to immunometabolism for immunologists. Nat. Rev. Immunol. 2016;16:553\u2013565. doi: 10.1038/nri.2016.70.", "ArticleIdList": ["10.1038/nri.2016.70", "PMC5001910", "27396447"]}, {"Citation": "Hortov\u00e1-Kohoutkov\u00e1 M., L\u00e1zni\u00e7kov\u00e1 P., Fri\u00e7 J. How immune-cell fate and function are determined by metabolic pathway choice: The bioenergetics underlying the immune response. Bioessays. 2021;43:e2000067. doi: 10.1002/bies.202000067.", "ArticleIdList": ["10.1002/bies.202000067", "33191545"]}, {"Citation": "Sun H., Li X. Metabolic Reprogramming in Resting and Activated Immune Cells. Metabolomics. 2017;7:188.", "ArticleIdList": ["PMC7351252", "32655978"]}, {"Citation": "Muri J., Kopf M. Redox regulation of immunometabolism. Nat. Rev. Immunol. 2021;21:363\u2013381. doi: 10.1038/s41577-020-00478-8.", "ArticleIdList": ["10.1038/s41577-020-00478-8", "33340021"]}, {"Citation": "Olenchock B.A., Rathmell J.C., Vander Heiden M.G. Biochemical Underpinnings of Immune Cell Metabolic Phenotypes. Immunity. 2017;46:703\u2013713. doi: 10.1016/j.immuni.2017.04.013.", "ArticleIdList": ["10.1016/j.immuni.2017.04.013", "PMC5660630", "28514672"]}, {"Citation": "Chi H. Immunometabolism at the intersection of metabolic signaling, cell fate, and systems immunology. Cell. Mol. Immunol. 2022;19:299\u2013302. doi: 10.1038/s41423-022-00840-x.", "ArticleIdList": ["10.1038/s41423-022-00840-x", "PMC8891332", "35190684"]}, {"Citation": "Raval F.M., Nikolajczyk B.S. The Bidirectional Relationship between Metabolism and Immune Responses. Discoveries. 2013;1:e6. doi: 10.15190/d.2013.6.", "ArticleIdList": ["10.15190/d.2013.6", "PMC4563811", "26366435"]}, {"Citation": "Zhang X., Zink F., Hezel F., Vogt J., Wachter U., Wepler M., Loconte M., Kranz C., Hellmann A., Mizaikoff B., et al. Metabolic substrate utilization in stress-induced immune cells. Intensive Care Med. Exp. 2020;8((Suppl. S1)):28. doi: 10.1186/s40635-020-00316-0.", "ArticleIdList": ["10.1186/s40635-020-00316-0", "PMC7746792", "33336295"]}, {"Citation": "Liu S., Sirohi K., Verma M., McKay J., Michalec L., Sripada A., Danhorn T., Rollins D., Good J., Gorska M.M., et al. Optimal identification of human conventional and nonconventional (CRTH2\u2212IL7R\u03b1\u2212) ILC2s using additional surface markers. J. Allergy Clin. Immunol. 2020;146:390\u2013405. doi: 10.1016/j.jaci.2020.01.038.", "ArticleIdList": ["10.1016/j.jaci.2020.01.038", "PMC7398840", "32032632"]}, {"Citation": "Eberl G., Colonna M., Di Santo J.P., McKenzie A.N. Innate lymphoid cells. Innate lymphoid cells: A new paradigm in immunology. Science. 2015;348:aaa6566. doi: 10.1126/science.aaa6566.", "ArticleIdList": ["10.1126/science.aaa6566", "PMC5658207", "25999512"]}, {"Citation": "Herbert D.R., Douglas B., Zullo K. Group 2 Innate Lymphoid Cells (ILC2): Type 2 Immunity and Helminth Immunity. Int. J. Mol. Sci. 2019;20:2276. doi: 10.3390/ijms20092276.", "ArticleIdList": ["10.3390/ijms20092276", "PMC6539149", "31072011"]}, {"Citation": "Konya V., Mj\u00f6sberg J. Lipid mediators as regulators of human ILC2 function in allergic diseases. Immunol. Lett. 2016;179:36\u201342. doi: 10.1016/j.imlet.2016.07.006.", "ArticleIdList": ["10.1016/j.imlet.2016.07.006", "27396531"]}, {"Citation": "Martinez-Gonzalez I., Steer C.A., Takei F. Lung ILC2s link innate and adaptive responses in allergic inflammation. Trends Immunol. 2015;36:189\u2013195. doi: 10.1016/j.it.2015.01.005.", "ArticleIdList": ["10.1016/j.it.2015.01.005", "25704560"]}, {"Citation": "Goretzki A., Zimmermann J., Rainer H., Lin Y.J., Sch\u00fclke S. Immune Metabolism in TH2 Responses: New Opportunities to Improve Allergy Treatment\u2014Disease-Specific Findings (Part 1) Curr. Allergy Asthma Rep. 2023;23:29\u201340. doi: 10.1007/s11882-022-01057-8.", "ArticleIdList": ["10.1007/s11882-022-01057-8", "PMC9832111", "36441389"]}, {"Citation": "Surace L., Doisne J.M., Croft C.A., Thaller A., Escoll P., Marie S., Petrosemoli N., Guillemot V., Dardalhon V., Topazio D., et al. Dichotomous metabolic networks govern human ILC2 proliferation and function. Nat. Immunol. 2021;22:1367\u20131374. doi: 10.1038/s41590-021-01043-8.", "ArticleIdList": ["10.1038/s41590-021-01043-8", "PMC8553616", "34686862"]}, {"Citation": "Pelletier A., Stockmann C. The Metabolic Basis of ILC Plasticity. Front. Immunol. 2022;13:858051. doi: 10.3389/fimmu.2022.858051.", "ArticleIdList": ["10.3389/fimmu.2022.858051", "PMC9099248", "35572512"]}, {"Citation": "Lombardi C., Berti A., Cottini M. The emerging roles of eosinophils: Implications for the targeted treatment of eosinophilic-associated inflammatory conditions. Curr. Res. Immunol. 2022;3:42\u201353. doi: 10.1016/j.crimmu.2022.03.002.", "ArticleIdList": ["10.1016/j.crimmu.2022.03.002", "PMC9040157", "35496822"]}, {"Citation": "Nussbaum J.C., Van Dyken S.J., von Moltke J., Cheng L.E., Mohapatra A., Molofsky A.B., Thornton E.E., Krummel M.F., Chawla A., Liang H.E., et al. Type 2 innate lymphoid cells control eosinophil homeostasis. Nature. 2013;502:245\u2013248. doi: 10.1038/nature12526.", "ArticleIdList": ["10.1038/nature12526", "PMC3795960", "24037376"]}, {"Citation": "Davoine F., Lacy P. Eosinophil cytokines, chemokines, and growth factors: Emerging roles in immunity. Front. Immunol. 2014;5:570. doi: 10.3389/fimmu.2014.00570.", "ArticleIdList": ["10.3389/fimmu.2014.00570", "PMC4225839", "25426119"]}, {"Citation": "Fettrelet T., Gigon L., Karaulov A., Yousefi S., Simon H.U. The Enigma of Eosinophil Degranulation. Int. J. Mol. Sci. 2021;22:7091. doi: 10.3390/ijms22137091.", "ArticleIdList": ["10.3390/ijms22137091", "PMC8268949", "34209362"]}, {"Citation": "Lacy P. Chapter 12\u2014Eosinophil cytokines in allergy. In: Foti M., Locati M., editors. Cytokine Effector Functions in Tissues. Academic Press; Cambridge, MA, USA: 2017. pp. 173\u2013218."}, {"Citation": "Martin L.B., Kita H., Leiferman K.M., Gleich G.J. Eosinophils in allergy: Role in disease, degranulation, and cytokines. Int. Arch. Allergy Immunol. 1996;109:207\u2013215. doi: 10.1159/000237239.", "ArticleIdList": ["10.1159/000237239", "8620088"]}, {"Citation": "Gigon L., Fettrelet T., Yousefi S., Simon D., Simon H.U. Eosinophils from A to Z. Allergy. 2023;78:1810\u20131846. doi: 10.1111/all.15751.", "ArticleIdList": ["10.1111/all.15751", "37102676"]}, {"Citation": "Jones N., Vincent E.E., Felix L.C., Cronin J.G., Scott L.M., Hole P.S., Lacy P., Thornton C.A. Interleukin-5 drives glycolysis and reactive oxygen species-dependent citric acid cycling by eosinophils. Allergy. 2020;75:1361\u20131370. doi: 10.1111/all.14158.", "ArticleIdList": ["10.1111/all.14158", "31856334"]}, {"Citation": "Wu W., Samoszuk M.K., Comhair S.A., Thomassen M.J., Farver C.F., Dweik R.A., Kavuru M.S., Erzurum S.C., Hazen S.L. Eosinophils generate brominating oxidants in allergen-induced asthma. J. Clin. Investig. 2000;105:1455\u20131463. doi: 10.1172/JCI9702.", "ArticleIdList": ["10.1172/JCI9702", "PMC315470", "10811853"]}, {"Citation": "Gaurav R., Bewtra A.K., Agrawal D.K. Chloride Channel 3 Channels in the Activation and Migration of Human Blood Eosinophils in Allergic Asthma. Am. J. Respir. Cell Mol. Biol. 2015;53:235\u2013245. doi: 10.1165/rcmb.2014-0300OC.", "ArticleIdList": ["10.1165/rcmb.2014-0300OC", "PMC4566046", "25514499"]}, {"Citation": "Yousefi S., Simon D., Simon H.U. Eosinophil extracellular DNA traps: Molecular mechanisms and potential roles in disease. Curr. Opin. Immunol. 2012;24:736\u2013739. doi: 10.1016/j.coi.2012.08.010.", "ArticleIdList": ["10.1016/j.coi.2012.08.010", "22981682"]}, {"Citation": "Choi Y., Le Pham D., Lee D.H., Lee S.H., Kim S.H., Park H.S. Biological function of eosinophil extracellular traps in patients with severe eosinophilic asthma. Exp. Mol. Med. 2018;50:1\u20138. doi: 10.1038/s12276-018-0136-8.", "ArticleIdList": ["10.1038/s12276-018-0136-8", "PMC6095846", "30115903"]}, {"Citation": "Silveira J.S., Antunes G.L., Kaiber D.B., da Costa M.S., Marques E.P., Ferreira F.S., Gassen R.B., Breda R.V., Wyse A.T.S., Pitrez P., et al. Reactive oxygen species are involved in eosinophil extracellular traps release and in airway inflammation in asthma. J. Cell. Physiol. 2019;234:23633\u201323646. doi: 10.1002/jcp.28931.", "ArticleIdList": ["10.1002/jcp.28931", "31180592"]}, {"Citation": "Schauberger E., Peinhaupt M., Cazares T., Lindsley A.W. Lipid Mediators of Allergic Disease: Pathways, Treatments, and Emerging Therapeutic Targets. Curr. Allergy Asthma Rep. 2016;16:48. doi: 10.1007/s11882-016-0628-3.", "ArticleIdList": ["10.1007/s11882-016-0628-3", "PMC5515624", "27333777"]}, {"Citation": "Nakamura T. The roles of lipid mediators in type I hypersensitivity. J. Pharmacol. Sci. 2021;147:126\u2013131. doi: 10.1016/j.jphs.2021.06.001.", "ArticleIdList": ["10.1016/j.jphs.2021.06.001", "34294363"]}, {"Citation": "Miyata J., Fukunaga K., Kawashima Y., Ohara O., Kawana A., Asano K., Arita M. Dysregulated metabolism of polyunsaturated fatty acids in eosinophilic allergic diseases. Prostaglandins Other Lipid Mediat. 2020;150:106477. doi: 10.1016/j.prostaglandins.2020.106477.", "ArticleIdList": ["10.1016/j.prostaglandins.2020.106477", "32711128"]}, {"Citation": "Wang B., Wu L., Chen J., Dong L., Chen C., Wen Z., Hu J., Fleming I., Wang D.W. Metabolism pathways of arachidonic acids: Mechanisms and potential therapeutic targets. Signal Transduct. Target. Ther. 2021;6:94. doi: 10.1038/s41392-020-00443-w.", "ArticleIdList": ["10.1038/s41392-020-00443-w", "PMC7910446", "33637672"]}, {"Citation": "Haeggstr\u00f6m J.Z., Funk C.D. Lipoxygenase and leukotriene pathways: Biochemistry, biology, and roles in disease. Chem. Rev. 2011;111:5866\u20135898. doi: 10.1021/cr200246d.", "ArticleIdList": ["10.1021/cr200246d", "21936577"]}, {"Citation": "Di Gennaro A., Haeggstr\u00f6m J.Z. The leukotrienes: Immune-modulating lipid mediators of disease. Adv. Immunol. 2012;116:51\u201392.", "ArticleIdList": ["23063073"]}, {"Citation": "Sasaki F., Yokomizo T. The leukotriene receptors as therapeutic targets of inflammatory diseases. Int. Immunol. 2019;31:607\u2013615. doi: 10.1093/intimm/dxz044.", "ArticleIdList": ["10.1093/intimm/dxz044", "31135881"]}, {"Citation": "Jo-Watanabe A., Okuno T., Yokomizo T. The Role of Leukotrienes as Potential Therapeutic Targets in Allergic Disorders. Int. J. Mol. Sci. 2019;20:3580. doi: 10.3390/ijms20143580.", "ArticleIdList": ["10.3390/ijms20143580", "PMC6679143", "31336653"]}, {"Citation": "Liu M., Yokomizo T. The role of leukotrienes in allergic diseases. Allergol. Int. 2015;64:17\u201326. doi: 10.1016/j.alit.2014.09.001.", "ArticleIdList": ["10.1016/j.alit.2014.09.001", "25572555"]}, {"Citation": "Steinke J.W., Borish L. Leukotriene receptors in rhinitis and sinusitis. Curr. Allergy Asthma Rep. 2004;4:217\u2013223. doi: 10.1007/s11882-004-0029-x.", "ArticleIdList": ["10.1007/s11882-004-0029-x", "15056404"]}, {"Citation": "Voisin T., Perner C., Messou M.A., Shiers S., Ualiyeva S., Kanaoka Y., Price T.J., Sokol C.L., Bankova L.G., Austen K.F., et al. The CysLT2R receptor mediates leukotriene C4-driven acute and chronic itch. Proc. Natl. Acad. Sci. USA. 2021;118:e2022087118. doi: 10.1073/pnas.2022087118.", "ArticleIdList": ["10.1073/pnas.2022087118", "PMC8020753", "33753496"]}, {"Citation": "Bankova L.G., Boyce J.A. A new spin on mast cells and cysteinyl leukotrienes: Leukotriene E4 activates mast cells in vivo. J. Allergy Clin. Immunol. 2018;142:1056\u20131057. doi: 10.1016/j.jaci.2018.08.008.", "ArticleIdList": ["10.1016/j.jaci.2018.08.008", "30165055"]}, {"Citation": "Salimi M., St\u00f6ger L., Liu W., Go S., Pavord I., Klenerman P., Ogg G., Xue L. Cysteinyl leukotriene E4 activates human group 2 innate lymphoid cells and enhances the effect of prostaglandin D2 and epithelial cytokines. J. Allergy Clin. Immunol. 2017;140:1090\u20131100.e11. doi: 10.1016/j.jaci.2016.12.958.", "ArticleIdList": ["10.1016/j.jaci.2016.12.958", "PMC5624780", "28115217"]}, {"Citation": "Henderson W.R., Jr., Tang L.O., Chu S.J., Tsao S.M., Chiang G.K., Jones F., Jonas M., Pae C., Wang H., Chi E.Y. A role for cysteinyl leukotrienes in airway remodeling in a mouse asthma model. Am. J. Respir. Crit. Care Med. 2002;165:108\u2013116. doi: 10.1164/ajrccm.165.1.2105051.", "ArticleIdList": ["10.1164/ajrccm.165.1.2105051", "11779739"]}, {"Citation": "Smyth E.M., Grosser T., Wang M., Yu Y., FitzGerald G.A. Prostanoids in health and disease. J. Lipid Res. 2009;50:S423\u2013S428. doi: 10.1194/jlr.R800094-JLR200.", "ArticleIdList": ["10.1194/jlr.R800094-JLR200", "PMC2674745", "19095631"]}, {"Citation": "Ricciotti E., FitzGerald G.A. Prostaglandins and inflammation. Arterioscler. Thromb. Vasc. Biol. 2011;31:986\u20131000. doi: 10.1161/ATVBAHA.110.207449.", "ArticleIdList": ["10.1161/ATVBAHA.110.207449", "PMC3081099", "21508345"]}, {"Citation": "Oyesola O.O., Tait Wojno E.D. Prostaglandin regulation of type 2 inflammation: From basic biology to therapeutic interventions. Eur. J. Immunol. 2021;51:2399\u20132416. doi: 10.1002/eji.202048909.", "ArticleIdList": ["10.1002/eji.202048909", "PMC8843787", "34396535"]}, {"Citation": "Peebles R.S., Jr. Prostaglandins in asthma and allergic diseases. Pharmacol. Ther. 2019;193:1\u201319. doi: 10.1016/j.pharmthera.2018.08.001.", "ArticleIdList": ["10.1016/j.pharmthera.2018.08.001", "PMC6309751", "30081047"]}, {"Citation": "Nakamura T., Murata T. Regulation of vascular permeability in anaphylaxis. Br. J. Pharmacol. 2018;175:2538\u20132542. doi: 10.1111/bph.14332.", "ArticleIdList": ["10.1111/bph.14332", "PMC6003654", "29671869"]}, {"Citation": "Kupczyk M., Kuna P. Targeting the PGD2/CRTH2/DP1 Signaling Pathway in Asthma and Allergic Disease: Current Status and Future Perspectives. Drugs. 2017;77:1281\u20131294. doi: 10.1007/s40265-017-0777-2.", "ArticleIdList": ["10.1007/s40265-017-0777-2", "PMC5529497", "28612233"]}, {"Citation": "Duffney P.F., Falsetta M.L., Rackow A.R., Thatcher T.H., Phipps R.P., Sime P.J. Key roles for lipid mediators in the adaptive immune response. J. Clin. Investig. 2018;128:2724\u20132731. doi: 10.1172/JCI97951.", "ArticleIdList": ["10.1172/JCI97951", "PMC6025978", "30108196"]}, {"Citation": "Basil M.C., Levy B.D. Specialized pro-resolving mediators: Endogenous regulators of infection and inflammation. Nat. Rev. Immunol. 2016;16:51\u201367. doi: 10.1038/nri.2015.4.", "ArticleIdList": ["10.1038/nri.2015.4", "PMC5242505", "26688348"]}, {"Citation": "Lotfi R., Rezaiemanesh A., Mortazavi S.H., Karaji A.G., Salari F. Immunoresolvents in asthma and allergic diseases: Review and update. J. Cell. Physiol. 2019;234:8579\u20138596. doi: 10.1002/jcp.27836.", "ArticleIdList": ["10.1002/jcp.27836", "30488527"]}, {"Citation": "Kapoor R., Menon C., Hoffstad O., Bilker W., Leclerc P., Margolis D.J. The prevalence of atopic triad in children with physician-confirmed atopic dermatitis. J. Am. Acad. Dermatol. 2008;58:68\u201373. doi: 10.1016/j.jaad.2007.06.041.", "ArticleIdList": ["10.1016/j.jaad.2007.06.041", "17692428"]}, {"Citation": "Peng W., Novak N. Pathogenesis of atopic dermatitis. Clin. Exp. Allergy. 2015;45:566\u2013574. doi: 10.1111/cea.12495.", "ArticleIdList": ["10.1111/cea.12495", "25610977"]}, {"Citation": "Luger T., Amagai M., Dreno B., Dagnelie M.A., Liao W., Kabashima K., Schikowski T., Proksch E., Elias P.M., Simon M., et al. Atopic dermatitis: Role of the skin barrier, environment, microbiome, and therapeutic agents. J. Dermatol. Sci. 2021;102:142\u2013157. doi: 10.1016/j.jdermsci.2021.04.007.", "ArticleIdList": ["10.1016/j.jdermsci.2021.04.007", "34116898"]}, {"Citation": "Afghani J., Traidl-Hoffmann C., Schmitt-Kopplin P., Reiger M., Mueller C. An Overview of the Latest Metabolomics Studies on Atopic Eczema with New Directions for Study. Int. J. Mol. Sci. 2022;23:8791. doi: 10.3390/ijms23158791.", "ArticleIdList": ["10.3390/ijms23158791", "PMC9368995", "35955924"]}, {"Citation": "Bhattacharya N., Sato W.J., Kelly A., Ganguli-Indra G., Indra A.K. Epidermal Lipids: Key Mediators of Atopic Dermatitis Pathogenesis. Trends Mol. Med. 2019;25:551\u2013562. doi: 10.1016/j.molmed.2019.04.001.", "ArticleIdList": ["10.1016/j.molmed.2019.04.001", "PMC6698381", "31054869"]}, {"Citation": "Pavel P., Leman G., Hermann M., Ploner C., Eichmann T.O., Minzaghi D., Radner F.P.W., Del Frari B., Gruber R., Dubrac S. Peroxisomal Fatty Acid Oxidation and Glycolysis Are Triggered in Mouse Models of Lesional Atopic Dermatitis. JID Innov. 2021;1:100033. doi: 10.1016/j.xjidi.2021.100033.", "ArticleIdList": ["10.1016/j.xjidi.2021.100033", "PMC8659757", "34909730"]}, {"Citation": "Huang Y., Chen G., Liu X., Shao Y., Gao P., Xin C., Cui Z., Zhao X., Xu G. Serum metabolomics study and eicosanoid analysis of childhood atopic dermatitis based on liquid chromatography-mass spectrometry. J. Proteome Res. 2014;13:5715\u20135723. doi: 10.1021/pr5007069.", "ArticleIdList": ["10.1021/pr5007069", "25316199"]}, {"Citation": "T\u00f6r\u00f6csik D., Weise C., Gericke J., Szegedi A., Lucas R., Mihaly J., Worm M., R\u00fchl R. Transcriptomic and lipidomic profiling of eicosanoid/docosanoid signalling in affected and non-affected skin of human atopic dermatitis patients. Exp. Dermatol. 2019;28:177\u2013189. doi: 10.1111/exd.13867.", "ArticleIdList": ["10.1111/exd.13867", "30575130"]}, {"Citation": "Nicolaou A. Eicosanoids in skin inflammation. Prostaglandins Leukot. Essent. Fat. Acids. 2013;88:131\u2013138. doi: 10.1016/j.plefa.2012.03.009.", "ArticleIdList": ["10.1016/j.plefa.2012.03.009", "22521864"]}, {"Citation": "Hamers A., Primus C.P., Whitear C., Kumar N.A., Masucci M., Montalvo Moreira S.A., Rathod K., Chen J., Bubb K., Colas R., et al. 20-hydroxyeicosatetraenoic acid (20-HETE) is a pivotal endogenous ligand for TRPV1-mediated neurogenic inflammation in the skin. Br. J. Pharmacol. 2022;179:1450\u20131469. doi: 10.1111/bph.15726.", "ArticleIdList": ["10.1111/bph.15726", "34755897"]}, {"Citation": "Kiezel-Tsugunova M., Kendall A.C., Nicolaou A. Fatty acids and related lipid mediators in the regulation of cutaneous inflammation. Biochem. Soc. Trans. 2018;46:119\u2013129. doi: 10.1042/BST20160469.", "ArticleIdList": ["10.1042/BST20160469", "29330355"]}, {"Citation": "Sakai T., Herrmann N., Maintz L., N\u00fcmm T.J., Welchowski T., Claus R.A., Gr\u00e4ler M.H., Bieber T. Serum sphingosine-1-phosphate is elevated in atopic dermatitis and associated with severity. Allergy. 2021;76:2592\u20132595. doi: 10.1111/all.14826.", "ArticleIdList": ["10.1111/all.14826", "33764548"]}, {"Citation": "Kleuser B., B\u00e4umer W. Sphingosine 1-Phosphate as Essential Signaling Molecule in Inflammatory Skin Diseases. Int. J. Mol. Sci. 2023;24:1456. doi: 10.3390/ijms24021456.", "ArticleIdList": ["10.3390/ijms24021456", "PMC9863039", "36674974"]}, {"Citation": "Wedman P.A., Aladhami A., Chumanevich A.P., Fuseler J.W., Oskeritzian C.A. Mast cells and sphingosine-1-phosphate underlie prelesional remodeling in a mouse model of eczema. Allergy. 2018;73:405\u2013415. doi: 10.1111/all.13310.", "ArticleIdList": ["10.1111/all.13310", "PMC10127444", "28905998"]}, {"Citation": "Cyster J.G., Schwab S.R. Sphingosine-1-phosphate and lymphocyte egress from lymphoid organs. Annu. Rev. Immunol. 2012;30:69\u201394. doi: 10.1146/annurev-immunol-020711-075011.", "ArticleIdList": ["10.1146/annurev-immunol-020711-075011", "22149932"]}, {"Citation": "Ottas A., Fishman D., Okas T.L., P\u00fcssa T., Toomik P., M\u00e4rtson A., Kingo K., Soomets U. Blood serum metabolome of atopic dermatitis: Altered energy cycle and the markers of systemic inflammation. PLoS ONE. 2017;12:e0188580. doi: 10.1371/journal.pone.0188580.", "ArticleIdList": ["10.1371/journal.pone.0188580", "PMC5703555", "29176763"]}, {"Citation": "Ma E.Z., Deng J., Parthasarathy V., Lee K.K., Pritchard T., Guo S., Zhang C., Kwatra M.M., Le A., Kwatra S.G. Integrated plasma metabolomic and cytokine analysis reveals a distinct immunometabolic signature in atopic dermatitis. Front. Immunol. 2024;15:1354128. doi: 10.3389/fimmu.2024.1354128.", "ArticleIdList": ["10.3389/fimmu.2024.1354128", "PMC10978712", "38558806"]}, {"Citation": "Oyoshi M.K., He R., Kanaoka Y., ElKhal A., Kawamoto S., Lewis C.N., Austen K.F., Geha R.S. Eosinophil-derived leukotriene C4 signals via type 2 cysteinyl leukotriene receptor to promote skin fibrosis in a mouse model of atopic dermatitis. Proc. Natl. Acad. Sci. USA. 2012;109:4992\u20134997. doi: 10.1073/pnas.1203127109.", "ArticleIdList": ["10.1073/pnas.1203127109", "PMC3323994", "22416124"]}, {"Citation": "Mashiko S., Mehta H., Bissonnette R., Sarfati M. Increased frequencies of baso-phils, type 2 innate lymphoid cells and Th2 cells in skin of patients with atopic dermatitis but not psoriasis. J. Dermatol. Sci. 2017;88:167\u2013174. doi: 10.1016/j.jdermsci.2017.07.003.", "ArticleIdList": ["10.1016/j.jdermsci.2017.07.003", "28743611"]}, {"Citation": "Alkon N., Bauer W.M., Krausgruber T., Goh I., Griss J., Nguyen V., Reininger B., Bangert C., Staud C., Brunner P.M., et al. Single-cell analysis reveals innate lymphoid cell lineage infidelity in atopic dermatitis. J. Allergy Clin. Immunol. 2022;149:624\u2013639. doi: 10.1016/j.jaci.2021.07.025.", "ArticleIdList": ["10.1016/j.jaci.2021.07.025", "PMC9130781", "34363841"]}, {"Citation": "Chang J.E., Doherty T.A., Baum R., Broide D. Prostaglandin D2 regulates human type 2 innate lymphoid cell chemotaxis. J. Allergy Clin. Immunol. 2014;133:899\u2013901.e3. doi: 10.1016/j.jaci.2013.09.020.", "ArticleIdList": ["10.1016/j.jaci.2013.09.020", "PMC3943597", "24210841"]}, {"Citation": "Bousquet J., Jeffery P.K., Busse W.W., Johnson M., Vignola A.M. Asthma. From bronchoconstriction to airways inflammation and remodeling. Am. J. Respir. Crit. Care Med. 2000;161:1720\u20131745. doi: 10.1164/ajrccm.161.5.9903102.", "ArticleIdList": ["10.1164/ajrccm.161.5.9903102", "10806180"]}, {"Citation": "Banno A., Reddy A.T., Lakshmi S.P., Reddy R.C. Bidirectional interaction of airway epithelial remodeling and inflammation in asthma. Clin. Sci. 2020;134:1063\u20131079. doi: 10.1042/CS20191309.", "ArticleIdList": ["10.1042/CS20191309", "32369100"]}, {"Citation": "Varricchi G., Ferri S., Pepys J., Poto R., Spadaro G., Nappi E., Paoletti G., Virchow J.C., Heffler E., Canonica W.G. Biologics and airway remodeling in severe asthma. Allergy. 2022;77:3538\u20133552. doi: 10.1111/all.15473.", "ArticleIdList": ["10.1111/all.15473", "PMC10087445", "35950646"]}, {"Citation": "Kubo M. Innate and adaptive type 2 immunity in lung allergic inflammation. Immunol. Rev. 2017;278:162\u2013172. doi: 10.1111/imr.12557.", "ArticleIdList": ["10.1111/imr.12557", "28658559"]}, {"Citation": "Zheng P., Bian X., Zhai Y., Li C., Li N., Hao C., Huang H., Luo W., Huang Z., Liao C., et al. Metabolomics reveals a correlation between hydroxyeicosatetraenoic acids and allergic asthma: Evidence from three years\u2019 immunotherapy. Pediatr. Allergy Immunol. 2021;32:1654\u20131662. doi: 10.1111/pai.13569.", "ArticleIdList": ["10.1111/pai.13569", "34087025"]}, {"Citation": "Gai X.Y., Zhang L.J., Chang C., Guo C.L., Abulikemu M., Li W.X., Wang J., Yao W.Z., Zhang X. Metabolomic Analysis of Serum Glycerophospholipid Levels in Eosinophilic and Neutrophilic Asthma. Biomed. Environ. Sci. 2019;32:96\u2013106.", "ArticleIdList": ["30862341"]}, {"Citation": "Kelly R.S., Virkud Y., Giorgio R., Celed\u00f3n J.C., Weiss S.T., Lasky-Su J. Metabolomic profiling of lung function in Costa-Rican children with asthma. Biochim. Biophys. Acta Mol. Basis Dis. 2017;1863:1590\u20131595. doi: 10.1016/j.bbadis.2017.02.006.", "ArticleIdList": ["10.1016/j.bbadis.2017.02.006", "PMC5474172", "28188833"]}, {"Citation": "Tian M., Chen M., Bao Y.L., Xu C.D., Qin Q.Z., Zhang W.X., He Y.T., Shao Q. Sputum metabolomic profiling of bronchial asthma based on quadruple time-of-flight mass spectrometry. Int. J. Clin. Exp. Pathol. 2017;10:10363\u201310373.", "ArticleIdList": ["PMC6965799", "31966372"]}, {"Citation": "Seng J.A., Nealon J.R., Blanksby S.J., Mitchell T.W. Distribution of Glycerophospholipids in the Adult Human Lens. Biomolecules. 2018;8:156. doi: 10.3390/biom8040156.", "ArticleIdList": ["10.3390/biom8040156", "PMC6315977", "30469542"]}, {"Citation": "Pascoe C.D., Jha A., Ryu M.H., Ragheb M., Vaghasiya J., Basu S., Stelmack G.L., Srinathan S., Kidane B., Kindrachuk J., et al. Allergen inhalation generates pro-inflammatory oxidised phosphatidylcholine associated with airway dysfunction. Eur. Respir. J. 2021;57:2000839. doi: 10.1183/13993003.00839-2020.", "ArticleIdList": ["10.1183/13993003.00839-2020", "32883680"]}, {"Citation": "Sano A., Sano H., Iwanaga T., Tohda Y. Functional role of phosphatidylcholine-specific phospholipase C in regulating leukotriene synthesis and degranulation in human eosinophils. Eur. J. Pharmacol. 2020;884:173353. doi: 10.1016/j.ejphar.2020.173353.", "ArticleIdList": ["10.1016/j.ejphar.2020.173353", "32707189"]}, {"Citation": "Ammit A.J., Hastie A.T., Edsall L.C., Hoffman R.K., Amrani Y., Krymskaya V.P., Kane S.A., Peters S.P., Penn R.B., Spiegel S., et al. Sphingosine 1-phosphate modulates human airway smooth muscle cell functions that promote inflammation and airway remodeling in asthma. FASEB J. 2001;15:1212\u20131214. doi: 10.1096/fj.00-0742fje.", "ArticleIdList": ["10.1096/fj.00-0742fje", "11344091"]}, {"Citation": "Costello R.W., Maloney M., Atiyeh M., Gleich G., Walsh M.T. Mechanism of sphingosine 1-phosphate- and lysophosphatidic acid-induced up-regulation of adhesion molecules and eosinophil chemoattractant in nerve cells. Int. J. Mol. Sci. 2011;12:3237\u20133249. doi: 10.3390/ijms12053237.", "ArticleIdList": ["10.3390/ijms12053237", "PMC3116188", "21686182"]}, {"Citation": "Fuerst E., Foster H.R., Ward J.P., Corrigan C.J., Cousins D.J., Woszczek G. Sphingosine-1-phosphate induces pro-remodelling response in airway smooth muscle cells. Allergy. 2014;69:1531\u20131539. doi: 10.1111/all.12489.", "ArticleIdList": ["10.1111/all.12489", "PMC4329332", "25041788"]}, {"Citation": "Nishiuma T., Nishimura Y., Okada T., Kuramoto E., Kotani Y., Jahangeer S., Nakamura S. Inhalation of sphingosine kinase inhibitor attenuates airway inflammation in asthmatic mouse model. Am. J. Physiol. Lung Cell. Mol. Physiol. 2008;294:L1085\u2013L1093. doi: 10.1152/ajplung.00445.2007.", "ArticleIdList": ["10.1152/ajplung.00445.2007", "18359884"]}, {"Citation": "Montuschi P., Santini G., Valente S., Mondino C., Macagno F., Cattani P., Zini G., Mores N. Liquid chromatography-mass spectrometry measurement of leukotrienes in asthma and other respiratory diseases. J Chromatogr B Analyt Technol Biomed Life Sci. 2014;964:12\u201325. doi: 10.1016/j.jchromb.2014.02.059.", "ArticleIdList": ["10.1016/j.jchromb.2014.02.059", "24656639"]}, {"Citation": "Wang H.B., Akuthota P., Kanaoka Y., Weller P.F. Airway eosinophil migration into lymph nodes in mice depends on leukotriene C4. Allergy. 2017;72:927\u2013936. doi: 10.1111/all.13094.", "ArticleIdList": ["10.1111/all.13094", "PMC5418101", "27874209"]}, {"Citation": "Gauvreau G.M., Parameswaran K.N., Watson R.M., O\u2019Byrne P.M. Inhaled leukotriene E(4), but not leukotriene D(4), increased airway inflammatory cells in subjects with atopic asthma. Am. J. Respir. Crit. Care Med. 2001;164:1495\u20131500. doi: 10.1164/ajrccm.164.8.2102033.", "ArticleIdList": ["10.1164/ajrccm.164.8.2102033", "11704602"]}, {"Citation": "Neves J.S., Radke A.L., Weller P.F. Cysteinyl leukotrienes acting via granule membrane-expressed receptors elicit secretion from within cell-free human eosinophil granules. J. Allergy Clin. Immunol. 2010;125:477\u2013482. doi: 10.1016/j.jaci.2009.11.029.", "ArticleIdList": ["10.1016/j.jaci.2009.11.029", "PMC2824614", "20159258"]}, {"Citation": "Pelaia C., Crimi C., Vatrella A., Busceti M.T., Gaudio A., Garofalo E., Bruni A., Terracciano R., Pelaia G. New treatments for asthma: From the pathogenic role of prostaglandin D2 to the therapeutic effects of fevipiprant. Pharmacol. Res. 2020;155:104490. doi: 10.1016/j.phrs.2019.104490.", "ArticleIdList": ["10.1016/j.phrs.2019.104490", "31682916"]}, {"Citation": "Tang M., Da X., Xu Z., Zhao X., Zhou H. UHPLC/MS-based metabolomics of asthmatic mice reveals metabolic changes in group 2 innate lymphoid cells. Int. Immunopharmacol. 2024;130:111775. doi: 10.1016/j.intimp.2024.111775.", "ArticleIdList": ["10.1016/j.intimp.2024.111775", "38430805"]}, {"Citation": "LeSuer W.E., Kienzl M., Ochkur S.I., Schicho R., Doyle A.D., Wright B.L., Rank M.A., Krupnick A.S., Kita H., Jacobsen E.A. Eosinophils promote effector functions of lung group 2 innate lymphoid cells in allergic airway inflammation in mice. J. Allergy Clin. Immunol. 2023;152:469\u2013485.e10. doi: 10.1016/j.jaci.2023.03.023.", "ArticleIdList": ["10.1016/j.jaci.2023.03.023", "PMC10503660", "37028525"]}, {"Citation": "Pawankar R., Mori S., Ozu C., Kimura S. Overview on the pathomechanisms of allergic rhinitis. Asia Pac. Allergy. 2011;3:157\u2013167. doi: 10.5415/apallergy.2011.1.3.157.", "ArticleIdList": ["10.5415/apallergy.2011.1.3.157", "PMC3206239", "22053313"]}, {"Citation": "Liva G.A., Karatzanis A.D., Prokopakis E.P. Review of Rhinitis: Classification, Types, Pathophysiology. J. Clin. Med. 2021;10:3183. doi: 10.3390/jcm10143183.", "ArticleIdList": ["10.3390/jcm10143183", "PMC8303640", "34300349"]}, {"Citation": "Nur Husna S.M., Tan H.T., Md Shukri N., Mohd Ashari N.S., Wong K.K. Nasal Epithelial Barrier Integrity and Tight Junctions Disruption in Allergic Rhinitis: Overview and Pathogenic Insights. Front. Immunol. 2021;12:663626. doi: 10.3389/fimmu.2021.663626.", "ArticleIdList": ["10.3389/fimmu.2021.663626", "PMC8176953", "34093555"]}, {"Citation": "Ma G.C., Wang T.S., Wang J., Ma Z.J., Pu S.B. Serum metabolomics study of patients with allergic rhinitis. Biomed. Chromatogr. 2020;34:e4739. doi: 10.1002/bmc.4739.", "ArticleIdList": ["10.1002/bmc.4739", "31692004"]}, {"Citation": "Liu F., Zhang J., Liu Y., Zhang N., Holtappels G., Lin P., Liu S., Bachert C. Inflammatory profiles in nasal mucosa of patients with persistent vs intermittent allergic rhinitis. Allergy. 2010;65:1149\u20131157. doi: 10.1111/j.1398-9995.2010.02340.x.", "ArticleIdList": ["10.1111/j.1398-9995.2010.02340.x", "20192943"]}, {"Citation": "Mackle T., Gendy S.S., Walsh M., McConn-Walsh R., Costello R.W., Walsh M.T. Role of sphingosine 1-phosphate receptor expression in eosinophils of patients with allergic rhinitis, and effect of topical nasal steroid treatment on this receptor expression. J. Laryngol. Otol. 2008;122:1309\u20131317. doi: 10.1017/S0022215108003241.", "ArticleIdList": ["10.1017/S0022215108003241", "18808729"]}, {"Citation": "Tojima I., Shimizu T. Group 2 innate lymphoid cells and eosinophilic chronic rhinosinusitis. Curr. Opin. Allergy Clin. Immunol. 2019;19:18\u201325. doi: 10.1097/ACI.0000000000000496.", "ArticleIdList": ["10.1097/ACI.0000000000000496", "30507713"]}, {"Citation": "Bandeira-Melo C., Bozza P.T., Weller P.F. The cellular biology of eosinophil eicosanoid formation and function. J. Allergy Clin. Immunol. 2002;109:393\u2013400. doi: 10.1067/mai.2002.121529.", "ArticleIdList": ["10.1067/mai.2002.121529", "11897981"]}, {"Citation": "Powell W.S., Rokach J. The eosinophil chemoattractant 5-oxo-ETE and the OXE receptor. Prog. Lipid Res. 2013;52:651\u2013665. doi: 10.1016/j.plipres.2013.09.001.", "ArticleIdList": ["10.1016/j.plipres.2013.09.001", "PMC5710732", "24056189"]}, {"Citation": "Lin L., Dai F., Wei J., Chen Z. Biological Roles of 5-Oxo-6,8,11,14-Eicosatetraenoic Acid and the OXE Receptor in Allergic Diseases: Collegium Internationale Allergologicum Update 2024. Int. Arch. Allergy Immunol. 2024;185:301\u2013310. doi: 10.1159/000535560.", "ArticleIdList": ["10.1159/000535560", "38176394"]}, {"Citation": "Kowal K., Gielicz A., Sanak M. The effect of allergen-induced bronchoconstriction on concentration of 5-oxo-ETE in exhaled breath condensate of house dust mite-allergic patients. Clin. Exp. Allergy. 2017;47:1253\u20131262. doi: 10.1111/cea.12990.", "ArticleIdList": ["10.1111/cea.12990", "28763131"]}, {"Citation": "Schj\u00f8dt M.S., G\u00fcrdeniz G., Chawes B. The Metabolomics of Childhood Atopic Diseases: A Comprehensive Pathway-Specific Review. Metabolites. 2020;10:511. doi: 10.3390/metabo10120511.", "ArticleIdList": ["10.3390/metabo10120511", "PMC7767195", "33339279"]}, {"Citation": "Lee S.Y., Park Y.M., Yoo H.J., Hong S.J. Metabolomic pathways in food allergy. Pediatr. Allergy Immunol. 2024;35:e14133. doi: 10.1111/pai.14133.", "ArticleIdList": ["10.1111/pai.14133", "38727629"]}, {"Citation": "van Ginkel C.D., Flokstra-de Blok B.M., Kollen B.J., Kukler J., Koppelman G.H., Dubois A.E. Loss-of-function variants of the filaggrin gene are associated with clinical reactivity to foods. Allergy. 2015;70:461\u2013464. doi: 10.1111/all.12569.", "ArticleIdList": ["10.1111/all.12569", "25620092"]}, {"Citation": "Park H.J., Lee S.W., Hong S. Regulation of Allergic Immune Responses by Microbial Metabolites. Immune Netw. 2018;18:e15. doi: 10.4110/in.2018.18.e15.", "ArticleIdList": ["10.4110/in.2018.18.e15", "PMC5833122", "29503745"]}, {"Citation": "Hu M., Alashkar Alhamwe B., Santner-Nanan B., Miethe S., Harb H., Renz H., Potaczek D.P., Nanan R.K. Short-Chain Fatty Acids Augment Differentiation and Function of Human Induced Regulatory T Cells. Int. J. Mol. Sci. 2022;23:5740. doi: 10.3390/ijms23105740.", "ArticleIdList": ["10.3390/ijms23105740", "PMC9143307", "35628549"]}, {"Citation": "Lee K., Kim S.H., Yoon H.J., Paik D.J., Kim J.M., Youn J. Bacillus-derived poly-\u03b3-glutamic acid attenuates allergic airway inflammation through a Toll-like receptor-4-dependent pathway in a murine model of asthma. Clin. Exp. Allergy. 2011;41:1143\u20131156. doi: 10.1111/j.1365-2222.2011.03792.x.", "ArticleIdList": ["10.1111/j.1365-2222.2011.03792.x", "21672055"]}, {"Citation": "Michaudel C., Sokol H. The Gut Microbiota at the Service of Immunometabolism. Cell Metab. 2020;32:514\u2013523. doi: 10.1016/j.cmet.2020.09.004.", "ArticleIdList": ["10.1016/j.cmet.2020.09.004", "32946809"]}, {"Citation": "Sturm E.M., Schratl P., Schuligoi R., Konya V., Sturm G.J., Lippe I.T., Peskar B.A., Heinemann A. Prostaglandin E2 inhibits eosinophil trafficking through E-prostanoid 2 receptors. J. Immunol. 2008;181:7273\u20137283. doi: 10.4049/jimmunol.181.10.7273.", "ArticleIdList": ["10.4049/jimmunol.181.10.7273", "18981149"]}, {"Citation": "Stepanovska B., Huwiler A. Targeting the S1P receptor signaling pathways as a promising approach for treatment of autoimmune and inflammatory diseases. Pharmacol. Res. 2020;154:104170. doi: 10.1016/j.phrs.2019.02.009.", "ArticleIdList": ["10.1016/j.phrs.2019.02.009", "30776422"]}, {"Citation": "Thieme M., Zillikens D., Sadik C.D. Sphingosine-1-phosphate modulators in inflammatory skin diseases\u2014Lining up for clinical translation. Exp. Dermatol. 2017;26:206\u2013210. doi: 10.1111/exd.13174.", "ArticleIdList": ["10.1111/exd.13174", "27574180"]}, {"Citation": "Karmouty-Quintana H., Siddiqui S., Hassan M., Tsuchiya K., Risse P.A., Xicota-Vila L., Marti-Solano M., Martin J.G. Treatment with a sphingosine-1-phosphate analog inhibits airway remodeling following repeated allergen exposure. Am. J. Physiol. Lung Cell. Mol. Physiol. 2012;302:L736\u2013L745. doi: 10.1152/ajplung.00050.2011.", "ArticleIdList": ["10.1152/ajplung.00050.2011", "22287614"]}, {"Citation": "Jutel M., Agache I., Zemelka-Wiacek M., Akdis M., Chivato T., Del Giacco S., Gajdanowicz P., Gracia I.E., Klimek L., Lauerma A., et al. Nomenclature of allergic diseases and hypersensitivity reactions: Adapted to modern needs: An EAACI position paper. Allergy. 2023;78:2851\u20132874. doi: 10.1111/all.15889.", "ArticleIdList": ["10.1111/all.15889", "37814905"]}]}], "History": [{"Year": "2024", "Month": "5", "Day": "29"}, {"Year": "2024", "Month": "6", "Day": "19"}, {"Year": "2024", "Month": "6", "Day": "20"}, {"Year": "2024", "Month": "7", "Day": "13", "Hour": "7", "Minute": "42"}, {"Year": "2024", "Month": "7", "Day": "13", "Hour": "7", "Minute": "41"}, {"Year": "2024", "Month": "7", "Day": "13", "Hour": "1", "Minute": "14"}, {"Year": "2024", "Month": "6", "Day": "24"}], "PublicationStatus": "epublish", "ArticleIdList": ["39000023", "PMC11241838", "10.3390/ijms25136913", "ijms25136913"]}}]}